Outcomes	O

The	O
primary	O
outcome	O
was	O
the	O
rate	B-PrimaryOutcome
of	I-PrimaryOutcome
positive	I-PrimaryOutcome
-	I-PrimaryOutcome
to	I-PrimaryOutcome
-	I-PrimaryOutcome
negative	I-PrimaryOutcome
conversion	I-PrimaryOutcome
of	I-PrimaryOutcome
SARS	I-PrimaryOutcome
-	I-PrimaryOutcome
CoV	I-PrimaryOutcome
-	I-PrimaryOutcome
2	I-PrimaryOutcome
nucleic	I-PrimaryOutcome
acid	I-PrimaryOutcome
from	B-TimeFrame
the	I-TimeFrame
initiation	I-TimeFrame
of	I-TimeFrame
treatment	I-TimeFrame
to	I-TimeFrame
day	I-TimeFrame
21	I-TimeFrame
,	O
with	O
the	O
enrollment	O
day	O
as	O
the	O
first	O
day	O
of	O
treatment	O
.	O

The	O
secondary	O
outcomes	O
were	O
:	O
1	O
)	O
the	O
rate	B-SecondaryOutcome
of	I-SecondaryOutcome
positive	I-SecondaryOutcome
-	I-SecondaryOutcome
to	I-SecondaryOutcome
-	I-SecondaryOutcome
negative	I-SecondaryOutcome
conversion	I-SecondaryOutcome
of	I-SecondaryOutcome
SARS	I-SecondaryOutcome
-	I-SecondaryOutcome
CoV	I-SecondaryOutcome
-	I-SecondaryOutcome
2	I-SecondaryOutcome
nucleic	I-SecondaryOutcome
acid	I-SecondaryOutcome
at	B-TimeFrame
day	I-TimeFrame
14	I-TimeFrame
;	O
2	O
)	O
the	B-SecondaryOutcome
rate	I-SecondaryOutcome
of	I-SecondaryOutcome
antipyresis	I-SecondaryOutcome
(	O
defined	O
as	O
axillary	B-OutcomeDefinition
temperature	I-OutcomeDefinition
≤	I-OutcomeDefinition
37	I-OutcomeDefinition
.	I-OutcomeDefinition
3	I-OutcomeDefinition
°	I-OutcomeDefinition
C	I-OutcomeDefinition
for	I-OutcomeDefinition
more	I-OutcomeDefinition
than	I-OutcomeDefinition
72	I-OutcomeDefinition
hours	I-OutcomeDefinition
)	O
from	B-TimeFrame
the	I-TimeFrame
first	I-TimeFrame
day	I-TimeFrame
of	I-TimeFrame
treatment	I-TimeFrame
;	O
3	O
)	O
the	O
rate	B-SecondaryOutcome
of	I-SecondaryOutcome
cough	I-SecondaryOutcome
alleviation	I-SecondaryOutcome
from	I-SecondaryOutcome
initiation	I-SecondaryOutcome
;	O
4	O
)	O
the	O
improvement	B-SecondaryOutcome
rate	I-SecondaryOutcome
of	I-SecondaryOutcome
chest	I-SecondaryOutcome
CT	I-SecondaryOutcome
at	B-TimeFrame
days	I-TimeFrame
7	I-TimeFrame
and	I-TimeFrame
14	I-TimeFrame
;	O
5	O
)	O
the	O
deterioration	B-SecondaryOutcome
rate	I-SecondaryOutcome
of	I-SecondaryOutcome
clinical	I-SecondaryOutcome
status	I-SecondaryOutcome
from	I-SecondaryOutcome
mild	I-SecondaryOutcome
/	I-SecondaryOutcome
moderate	I-SecondaryOutcome
to	I-SecondaryOutcome
severe	I-SecondaryOutcome
/	I-SecondaryOutcome
critical	I-SecondaryOutcome
status	I-SecondaryOutcome
during	B-TimeFrame
the	I-TimeFrame
study	I-TimeFrame
period	I-TimeFrame
.	O

The	O
severe	O
status	O
was	O
defined	O
as	O
meeting	B-OutcomeDefinition
any	I-OutcomeDefinition
of	I-OutcomeDefinition
the	I-OutcomeDefinition
following	I-OutcomeDefinition
criteria	I-OutcomeDefinition
:	I-OutcomeDefinition
experiencing	I-OutcomeDefinition
respiratory	I-OutcomeDefinition
distress	I-OutcomeDefinition
,	I-OutcomeDefinition
RR	I-OutcomeDefinition
≥	I-OutcomeDefinition
30	I-OutcomeDefinition
times	I-OutcomeDefinition
/	I-OutcomeDefinition
minute	I-OutcomeDefinition
;	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
saturation	I-OutcomeDefinition
≤	I-OutcomeDefinition
93	I-OutcomeDefinition
%	I-OutcomeDefinition
in	I-OutcomeDefinition
the	I-OutcomeDefinition
resting	I-OutcomeDefinition
state	I-OutcomeDefinition
;	I-OutcomeDefinition
arterial	I-OutcomeDefinition
blood	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
partial	I-OutcomeDefinition
pressure	I-OutcomeDefinition
(	I-OutcomeDefinition
PaO2	I-OutcomeDefinition
)	I-OutcomeDefinition
/	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
concentration	I-OutcomeDefinition
(	I-OutcomeDefinition
FiO2	I-OutcomeDefinition
)	I-OutcomeDefinition
≤	I-OutcomeDefinition
300	I-OutcomeDefinition
mmHg	I-OutcomeDefinition
(	I-OutcomeDefinition
1mmHg	I-OutcomeDefinition
=	I-OutcomeDefinition
0	I-OutcomeDefinition
.	I-OutcomeDefinition
133kPa	I-OutcomeDefinition
)	I-OutcomeDefinition
.	O
5	O
The	O
critical	O
status	O
was	O
defined	O
as	O
meeting	B-OutcomeDefinition
any	I-OutcomeDefinition
of	I-OutcomeDefinition
the	I-OutcomeDefinition
following	I-OutcomeDefinition
criteria	I-OutcomeDefinition
:	I-OutcomeDefinition
development	I-OutcomeDefinition
of	I-OutcomeDefinition
respiratory	I-OutcomeDefinition
failure	I-OutcomeDefinition
requiring	I-OutcomeDefinition
mechanical	I-OutcomeDefinition
ventilation	I-OutcomeDefinition
;	I-OutcomeDefinition
occurrence	I-OutcomeDefinition
of	I-OutcomeDefinition
shock	I-OutcomeDefinition
;	I-OutcomeDefinition
requirement	I-OutcomeDefinition
for	I-OutcomeDefinition
ICU	I-OutcomeDefinition
monitoring	I-OutcomeDefinition
and	I-OutcomeDefinition
treatment	I-OutcomeDefinition
because	I-OutcomeDefinition
of	I-OutcomeDefinition
complications	I-OutcomeDefinition
with	I-OutcomeDefinition
other	I-OutcomeDefinition
organ	I-OutcomeDefinition
failures	I-OutcomeDefinition
.	O
5	O

Specimens	O
from	O
pharyngeal	O
swabs	O
were	O
tested	O
every	O
2	O
to	O
3	O
days	O
.	O

Negative	O
conversion	O
of	O
nucleic	O
acid	O
was	O
defined	O
as	O
negative	B-OutcomeDefinition
detection	I-OutcomeDefinition
of	I-OutcomeDefinition
SARS	I-OutcomeDefinition
-	I-OutcomeDefinition
CoV	I-OutcomeDefinition
-	I-OutcomeDefinition
2	I-OutcomeDefinition
nucleic	I-OutcomeDefinition
acid	I-OutcomeDefinition
for	I-OutcomeDefinition
two	I-OutcomeDefinition
consecutive	I-OutcomeDefinition
instances	I-OutcomeDefinition
separated	I-OutcomeDefinition
by	I-OutcomeDefinition
more	I-OutcomeDefinition
than	I-OutcomeDefinition
24	I-OutcomeDefinition
hours	I-OutcomeDefinition
.	O

Criteria	B-OutcomeDefinition
of	I-OutcomeDefinition
chest	I-OutcomeDefinition
CT	I-OutcomeDefinition
improvement	I-OutcomeDefinition
included	I-OutcomeDefinition
:	I-OutcomeDefinition
1	I-OutcomeDefinition
)	I-OutcomeDefinition
no	I-OutcomeDefinition
new	I-OutcomeDefinition
exudative	I-OutcomeDefinition
lesions	I-OutcomeDefinition
;	I-OutcomeDefinition
2	I-OutcomeDefinition
)	I-OutcomeDefinition
decreasing	I-OutcomeDefinition
size	I-OutcomeDefinition
of	I-OutcomeDefinition
exudative	I-OutcomeDefinition
lesions	I-OutcomeDefinition
;	I-OutcomeDefinition
3	I-OutcomeDefinition
)	I-OutcomeDefinition
decreasing	I-OutcomeDefinition
densities	I-OutcomeDefinition
of	I-OutcomeDefinition
lesions	I-OutcomeDefinition
.	O

All	O
participants	O
were	O
monitored	O
for	O
adverse	B-OtherOutcome
events	I-OtherOutcome
.	O

Safety	O
outcomes	O
were	O
assessed	O
from	O
serious	B-OtherOutcome
adverse	I-OtherOutcome
event	I-OtherOutcome
reports	O
.	O

Any	O
unexpected	O
medical	O
occurrence	O
resulting	O
in	O
death	O
,	O
prolonged	O
hospitalization	O
,	O
persistent	O
or	O
significant	O
disability	O
or	O
incapacity	O
,	O
which	O
was	O
judged	O
to	O
be	O
causally	O
related	O
to	O
the	O
study	O
intervention	O
,	O
would	O
be	O
reported	O
as	O
a	O
serious	O
adverse	O
event	O
to	O
the	O

Institutional	O
Review	O
Board	O
.	O

Potential	O
adverse	O
events	O
for	O
the	O
study	O
were	O
defined	O
as	O
follows	O
(	B-OutcomeDefinition
1	I-OutcomeDefinition
)	I-OutcomeDefinition
anaphylaxis	I-OutcomeDefinition
;	I-OutcomeDefinition
(	I-OutcomeDefinition
2	I-OutcomeDefinition
)	I-OutcomeDefinition
elevation	I-OutcomeDefinition
of	I-OutcomeDefinition
ALT	I-OutcomeDefinition
or	I-OutcomeDefinition
AST	I-OutcomeDefinition
to	I-OutcomeDefinition
more	I-OutcomeDefinition
than	I-OutcomeDefinition
2	I-OutcomeDefinition
.	I-OutcomeDefinition
5	I-OutcomeDefinition
-	I-OutcomeDefinition
fold	I-OutcomeDefinition
the	I-OutcomeDefinition
upper	I-OutcomeDefinition
normal	I-OutcomeDefinition
limit	I-OutcomeDefinition
or	I-OutcomeDefinition
elevation	I-OutcomeDefinition
of	I-OutcomeDefinition
TBIL	I-OutcomeDefinition
to	I-OutcomeDefinition
more	I-OutcomeDefinition
than	I-OutcomeDefinition
1	I-OutcomeDefinition
.	I-OutcomeDefinition
5	I-OutcomeDefinition
-	I-OutcomeDefinition
fold	I-OutcomeDefinition
the	I-OutcomeDefinition
upper	I-OutcomeDefinition
normal	I-OutcomeDefinition
limit	I-OutcomeDefinition
;	I-OutcomeDefinition
(	I-OutcomeDefinition
3	I-OutcomeDefinition
)	I-OutcomeDefinition
acute	I-OutcomeDefinition
pancreatitis	I-OutcomeDefinition
;	I-OutcomeDefinition
and	I-OutcomeDefinition
(	I-OutcomeDefinition
4	I-OutcomeDefinition
)	I-OutcomeDefinition
diarrhea	I-OutcomeDefinition
.	O

